Effect of quantitative nuclear image features on recurrence of Ductal Carcinoma In Situ (DCIS) of the breast.
BACKGROUND
Nuclear grade has been associated with breast DCIS recurrence and progression to invasive carcinoma; however, our previous study of a cohort of patients with breast DCIS did not find such an association with outcome. Fifty percent of patients had heterogeneous DCIS with more than one nuclear grade. The aim of the current study was to investigate the effect of quantitative nuclear features assessed with digital image analysis on ipsilateral DCIS recurrence.


METHODS
Hematoxylin and eosin stained slides for a cohort of 80 patients with primary breast DCIS were reviewed and two fields with representative grade (or grades) were identified by a Pathologist and simultaneously used for acquisition of digital images for each field. Van Nuys worst nuclear grade was assigned, as was predominant grade, and heterogeneous grading when present. Patients were grouped by heterogeneity of their nuclear grade: Group A: nuclear grade 1 only, nuclear grades 1 and 2, or nuclear grade 2 only (32 patients), Group B: nuclear grades 1, 2 and 3, or nuclear grades 2 and 3 (31 patients), Group 3: nuclear grade 3 only (17 patients). Nuclear fine structure was assessed by software which captured thirty-nine nuclear feature values describing nuclear morphometry, densitometry, and texture. Step-wise forward Cox regressions were performed with previous clinical and pathologic factors, and the new image analysis features.


RESULTS
Duplicate measurements were similar for 89.7% to 97.4% of assessed image features. The rate of correct classification of nuclear grading with digital image analysis features was similar in the two fields, and pooled assessment across both fields. In the pooled assessment, a discriminant function with one nuclear morphometric and one texture feature was significantly (p = 0.001) associated with nuclear grading, and provided correct jackknifed classification of a patient's nuclear grade for Group A (78.1%), Group B (48.4%), and Group C (70.6%). The factors significantly associated with DCIS recurrence were those previously found, type of initial presentation (p = 0.03) and amount of parenchymal involvement (p = 0.05), along with the morphometry image feature of ellipticity (p = 0.04).


CONCLUSIONS
Analysis of nuclear features measured by image cytometry may contribute to the classification and prognosis of breast DCIS patients with more than one nuclear grade.
Axelrod
David E
DE
Department of Genetics and Cancer Institute of New Jersey, Rutgers-The State University of New Jersey, Piscataway, NJ 08854-8082, USA. axelrod@biology.rutgers.edu
Miller
Naomi A
NA
Lickley
H Lavina
HL
Qian
Jin
J
Christens-Barry
William A
WA
Yuan
Yan
Y
Fu
Yuejiao
Y
Chapman
Judith-Anne W
JA
Eur J Cancer. 1992;28(2-3):626-9
1317200
Eur J Cancer. 1999 May;35(5):714-20
10505030
CA Cancer J Clin. 2002 Sep-Oct;52(5):256-76
12363325
Anal Quant Cytol Histol. 2000 Dec;22(6):483-5
11147303
Br J Surg. 1987 Oct;74(10):905-6
2822199
J Natl Cancer Inst. 2004 Jun 16;96(12):906-20
15199110
J Pathol. 2001 Jan;193(1):33-9
11169513
Cancer. 1989 Feb 15;63(4):618-24
2536582
Cancer. 1996 Jun 1;77(11):2267-74
8635094
Cancer. 1991 Nov 1;68(9):2012-6
1655233
Breast Cancer Res Treat. 2002 Jun;73(3):215-21
12160327
Annu Rev Med. 2000;51:17-32
10774450
Semin Diagn Pathol. 1994 Aug;11(3):167-80
7831528
Anal Quant Cytol Histol. 1993 Dec;15(6):383-8
7507673
J Natl Cancer Inst. 2003 Nov 19;95(22):1692-702
14625260
Anal Quant Cytol. 1980 Mar-Apr;2(1):19-24
6990845
Hum Pathol. 1999 Mar;30(3):257-62
10088542
Cytometry. 2000 Oct 1;41(2):133-8
11002269
Pathol Res Pract. 1996 May;192(5):428-36
8832747
Mod Pathol. 1998 Feb;11(2):140-54
9504685
Anal Quant Cytol Histol. 2003 Dec;25(6):321-31
14714298
N Engl J Med. 2004 Apr 1;350(14):1430-41
15070793
Biometrics. 1979 Dec;35(4):861-7
393312
Nat Rev Cancer. 2007 Apr;7(4):309-15
17384585
Am J Clin Pathol. 1996 Sep;106(3):312-8
8816587
Am J Clin Pathol. 2001 May;115(5):709-18
11345835
J Histochem Cytochem. 1976 Jan;24(1):138-44
56387
Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):249-59
11303595
BMC Cancer. 2007 Sep 10;7:174
17845726
Histopathology. 1996 Nov;29(5):397-409
8951484
Breast J. 2001 Sep-Oct;7(5):292-302
11906438
Anal Cell Pathol. 1995 Jan;8(1):39-52
7734410
Anal Quant Cytol Histol. 2001 Dec;23(6):418-26
11777277
Hum Pathol. 1998 Sep;29(9):915-23
9744307
Hum Pathol. 1995 Jul;26(7):792-6
7628853
Anal Quant Cytol Histol. 1996 Dec;18(6):481-93
8978872
Cancer. 1997 Nov 1;80(9):1798-802
9351550
Ann Surg Oncol. 1998 Dec;5(8):724-32
9869520
Lancet. 1995 May 6;345(8958):1154-7
7723550
Anal Cell Pathol. 1998;17(4):209-17
10391373